Mismatch Repair Deficiency clinical trials at UCSF
1 research study open to eligible people
Mismatch repair deficiency is when the body cannot repair some DNA mistakes after cells divide. UCSF is running studies that use AI to find trial matches and store patient data in an international registry. UCSF is also testing treatments for cancers linked to this repair defect.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
open to all eligible people
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
San Francisco, California and other locations
Last updated: